Talk:Jambu: Difference between revisions
Dridhabala (talk | contribs) No edit summary |
Dridhabala (talk | contribs) No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 74: | Line 74: | ||
* Syzygium pseudojambolana Miq. | * Syzygium pseudojambolana Miq. | ||
* Syzygium tenue (Duthie) N.P.Balakr | * Syzygium tenue (Duthie) N.P.Balakr | ||
== Identification Characters & Botanical Profile == | == Identification Characters & Botanical Profile == | ||
| Line 198: | Line 196: | ||
== Phytochemical Composition == | == Phytochemical Composition == | ||
The therapeutic versatility of ''Syzygium cumini'' arises from its | The therapeutic versatility of ''Syzygium cumini'' arises from its secondary metabolite profile across the seeds, bark, and fruit: | ||
* '''Anthocyanins | * '''Anthocyanins:''' Anthocyanins responsible for the deep purple pigmentation are present in the fruit peel; their chemical nature, stability and bioefficacies have been characterized.<ref name="Veigas2007"/> | ||
* '''Phenolic | * '''Flavonoids & Phenolic Compounds:''' Fruit contains anthocyanin 3,5-diglucosides, dihydromyricetin diglucosides, myricetin glucoside and a galloyl-glucose ester.<ref name="Faria2011"/> | ||
* '''Glycosides & Alkaloids:''' | * '''Glycosides & Alkaloids:''' The plant is rich in anthocyanins, glucoside, ellagic acid, isoquercetin, kaempferol and myricetin, and the seeds are reported to contain the alkaloid jambosine and the glycoside jambolin (antimellin), claimed to halt the conversion of starch into sugar.<ref name="Ayyanar2012"/> | ||
== Pharmacological Activities & Therapeutic Efficacy == | == Pharmacological Activities & Therapeutic Efficacy == | ||
=== Anti-Diabetic and Hypoglycemic Potential === | === Anti-Diabetic and Hypoglycemic Potential === | ||
Jambu | Jambu seed is classically indicated in Madhumeha and is among the plants most often recommended as adjuvant therapy in type 2 diabetes. | ||
* '''Mechanism:''' | * '''Mechanism:''' Not established; mechanistic data come mainly from animal and in vitro studies. | ||
* '''Scientific Evidence:''' | * '''Scientific Evidence:''' A review of 125 years of research found about 100 case reports from the pre-insulin era and many animal studies reporting some reduction of type 2 diabetes symptoms; however, a state-of-the-art clinical study is still missing, so efficacy in humans is not established.<ref name="Helmstadter2008"/> | ||
=== Antioxidant and Free Radical Scavenging Action === | === Antioxidant and Free Radical Scavenging Action === | ||
Polyphenols and anthocyanins in the fruit are considered responsible for antioxidant protection. | |||
* '''Mechanism:''' | * '''Mechanism:''' Scavenging of free radicals; the activity of the fruit skin may come partly from antioxidant vitamins, phenolics or tannins and anthocyanins. | ||
* '''Scientific Evidence:''' DPPH, | * '''Scientific Evidence:''' In vitro assays of fruit skin extract (hydroxyl radical, superoxide, DPPH scavenging, lipid peroxidation and total antioxidant capacity) demonstrated antioxidant activity.<ref name="Banerjee2005"/> | ||
=== Gastroprotective Efficacy === | |||
The bark has prominent astringent properties and is classically used in Atisara; experimental evidence cited here concerns gastric mucosal protection. | |||
* '''Mechanism:''' Tannins reduced free-radical concentration in the stomach after gastric injury. | |||
* '''Scientific Evidence:''' In rats with HCl/ethanol-induced gastric mucosal damage, tannins (13.4% quantified) extracted from the bark significantly decreased gastric mucosal damage (p<0.01) on microscopic examination, indicating gastroprotective and anti-ulcerogenic effects.<ref name="Ramirez2003"/> | |||
=== | === Anti-inflammatory Properties === | ||
Jambu bark has shown anti-inflammatory activity in experimental models. | |||
* '''Mechanism:''' | * '''Mechanism:''' Probably inhibition of prostaglandin biosynthesis, related to the high tannin content of the bark extract (proposed, not proven). | ||
* '''Scientific Evidence:''' | * '''Scientific Evidence:''' The ethanolic extract of stem bark showed anti-inflammatory activity in rat models of experimentally induced inflammation.<ref name="Muruganandan2001"/> | ||
=== Antimicrobial | === Antimicrobial Properties === | ||
* '''Mechanism:''' Not established. | |||
* '''Mechanism:''' | * '''Scientific Evidence:''' Seed extracts of ''Syzygium jambolanum'' were reported to have antibacterial and antifungal activity in vitro.<ref name="Chandrasekaran2004"/> | ||
* '''Scientific Evidence:''' | |||
== Safety, Toxicity, and Dosage == | == Safety, Toxicity, and Dosage == | ||
* '''Toxicity Profile:''' | * '''Toxicity Profile:''' In rodents, an oral hydroalcoholic leaf extract caused no deaths up to 6 g/kg in mice and 2 g/kg in rats, and daily oral doses of 0.05–0.25 g/kg for up to 180 days caused no deaths or behavioural changes and normal organ histology; some biochemical changes occurred, and male rats at the highest dose did not gain weight from the 15th week. Intraperitoneal administration was toxic (LD50 0.489 g/kg in mice). These data are from leaf extract; equivalent data for seed and bark were not found.<ref name="Silva2012"/> | ||
* '''Precautions:''' | * '''Precautions:''' Classical texts describe Jambu as Vata-aggravating (Su. 25/40) and unwholesome in Ashmari (Chi. 26/76); see the Charak Samhita reference table above. | ||
* '''Standard Therapeutic Dosage:''' | * '''Standard Therapeutic Dosage:''' | ||
** *Seed Powder:* 3–6 g | ** *Seed Powder:* 3–6 g (see Dose above). | ||
** *Stem Bark Decoction:* 10–20 g. | ** *Stem Bark Decoction:* 10–20 g (see Dose above). | ||
== Summary of Therapeutic Profile == | == Summary of Therapeutic Profile == | ||
| Line 239: | Line 241: | ||
|- | |- | ||
| '''Diabetes Mellitus (Madhumeha)''' | | '''Diabetes Mellitus (Madhumeha)''' | ||
| | | Seed constituents (jambolin, reported) | ||
| | | Hypoglycemic (historical reports, animal studies; clinical evidence lacking) | ||
|- | |||
| '''Gastric Mucosal Injury (Atisara – classical use)''' | |||
| Bark tannins | |||
| Astringent, gastroprotective (animal) | |||
|- | |- | ||
| ''' | | '''Oxidative Stress''' | ||
| | | Anthocyanins, phenolics | ||
| | | Free radical scavenger (in vitro) | ||
|- | |- | ||
| ''' | | '''Inflammation''' | ||
| | | Bark tannins | ||
| | | Anti-inflammatory (animal) | ||
|- | |- | ||
| '''Microbial Infections''' | | '''Microbial Infections''' | ||
| | | Seed extract constituents | ||
| Antibacterial | | Antibacterial, antifungal (in vitro) | ||
|} | |} | ||
| Line 258: | Line 264: | ||
{{Reflist|refs= | {{Reflist|refs= | ||
<ref name="API">Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume 2:26</ref> | <ref name="API">Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume 2:26</ref> | ||
<ref name=" | <ref name="Veigas2007">{{cite journal |last1=Veigas |first1=J.M. |display-authors=etal |year=2007 |title=Chemical nature, stability and bioefficacies of anthocyanins from fruit peel of Syzygium cumini Skeels |journal=Food Chemistry |volume=105 |issue=2 |pages=619–627}}</ref> | ||
<ref name=" | <ref name="Faria2011">{{cite journal |last1=Faria |first1=A.F. |last2=Marques |first2=M.C. |last3=Mercadante |first3=A.Z. |year=2011 |title=Identification of bioactive compounds from jambolão (Syzygium cumini) and antioxidant capacity evaluation in different pH conditions |journal=Food Chemistry |volume=126 |issue=4 |pages=1571–1578 |doi=10.1016/j.foodchem.2010.12.007}}</ref> | ||
<ref name=" | <ref name="Ayyanar2012">{{cite journal |last1=Ayyanar |first1=M. |last2=Subash-Babu |first2=P. |year=2012 |title=Syzygium cumini (L.) Skeels: A review of its phytochemical constituents and traditional uses |journal=Asian Pacific Journal of Tropical Biomedicine |volume=2 |issue=3 |pages=240–246 |pmid=23569906}}</ref> | ||
<ref name=" | <ref name="Helmstadter2008">{{cite journal |last1=Helmstädter |first1=A. |year=2008 |title=Syzygium cumini (L.) Skeels (Myrtaceae) against diabetes – 125 years of research |journal=Die Pharmazie |volume=63 |issue=2 |pages=91–101 |doi=10.1691/ph.2008.7335}}</ref> | ||
<ref name="Banerjee2005">{{cite journal |last1=Banerjee |first1=A. |last2=Dasgupta |first2=N. |last3=De |first3=B. |year=2005 |title=In vitro study of antioxidant activity of Syzygium cumini fruit |journal=Food Chemistry |volume=90 |issue=4 |pages=727–733}}</ref> | |||
<ref name="Ramirez2003">{{cite journal |last1=Ramirez |first1=R.O. |last2=Roa |first2=C.C. Jr. |year=2003 |title=The gastroprotective effect of tannins extracted from duhat (Syzygium cumini Skeels) bark on HCl/ethanol induced gastric mucosal injury in Sprague-Dawley rats |journal=Clinical Hemorheology and Microcirculation |volume=29 |issue=3–4 |pages=253–261 |doi=10.3233/CHM-2003-599}}</ref> | |||
<ref name="Muruganandan2001">{{cite journal |last1=Muruganandan |first1=S. |last2=Srinivasan |first2=K. |last3=Chandra |first3=S. |last4=Tandan |first4=S.K. |last5=Lal |first5=J. |last6=Raviprakash |first6=V. |year=2001 |title=Anti-inflammatory activity of Syzygium cumini bark |journal=Fitoterapia |volume=72 |issue=4 |pages=369–375}}</ref> | |||
<ref name="Chandrasekaran2004">{{cite journal |last1=Chandrasekaran |first1=M. |last2=Venkatesalu |first2=V. |year=2004 |title=Antibacterial and antifungal activity of Syzygium jambolanum seeds |journal=Journal of Ethnopharmacology |volume=91 |issue=1 |pages=105–108}}</ref> | |||
<ref name="Silva2012">{{cite journal |last1=Silva |first1=S.N. |last2=Abreu |first2=I.C. |last3=Silva |first3=G.F.C. |display-authors=etal |year=2012 |title=The toxicity evaluation of Syzygium cumini leaves in rodents |journal=Revista Brasileira de Farmacognosia |url=https://www.scielo.br/j/rbfar/a/HcPwvtg7N5Yvgh578z4cbLq/}}</ref> | |||
}} | }} | ||
[[Index.php?title=Category:Database of herbs and minerals| Herbs]] | [[Index.php?title=Category:Database of herbs and minerals| Herbs]] | ||